CTKB · Cytek Biosciences, Inc.

$4.69 -0.20 (-4.09%) At close · Aug 14

Market Cap

$609.62M

129.98M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	Chief Executive Officer and President	$620,000	—	$2,000,000	$2,000,000	$485,211	$14,850	$5,120,061
William McCombe	Chief Financial Officer	$450,000	—	$900,000	$900,000	$210,979	—	$2,460,979
Valerie Barnett	Chief Legal Officer and Corporate Secretary	$475,000	—	$750,000	$750,000	$186,049	$13,894	$2,174,943
Ming Yan	Chief Technology Officer	$425,000	—	$425,000	$425,000	$166,550	$15,870	$1,457,420
Philippe Busque	Senior Vice President, Global Sales and Services	$375,000	—	$250,000	$250,000	$146,730	—	$1,021,730

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	Chief Executive Officer and President	$599,083	—	$2,499,994	$2,499,996	$472,677	$12,921	$6,084,671
Valerie Barnett	Chief Legal Officer and Corporate Secretary	$463,750	—	$874,997	$874,998	$182,949	$13,794	$2,410,489
Chris Williams	Former Chief Operating Officer	$323,878	—	$999,995	$999,999	—	$14,575	$2,338,447
Ming Yan	Chief Technology Officer	$424,959	—	$624,995	$624,996	$167,646	$13,954	$1,856,550
William McCombe	Chief Financial Officer	$315,000	—	$624,996	$624,998	$124,268	—	$1,689,261
Philippe Busque	Senior Vice President, Global Sales and Services	$359,585	—	$249,995	$249,997	$145,183	—	$1,004,760
Patrik Jeanmonod	Former Chief Financial Officer	$297,833	—	$249,993	$149,996	$46,998	$13,350	$758,171

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	Chief Executive Officer and President	$578,000	—	$2,000,000	$2,000,000	$311,378	$49,864	$4,939,242
Ming Yan	Chief Technology Officer	$424,000	—	$1,250,000	$1,250,000	$114,210	$31,912	$3,070,122
Valerie Barnett	Chief Legal Officer and Corporate Secretary	$435,000	—	$625,000	$625,000	$140,333	$37,061	$1,862,394
Patrik Jeanmonod	Former Chief Financial Officer	$408,000	—	$625,000	$625,000	$109,901	$18,187	$1,786,088
Allen Poirson	Senior Vice President, Business and Corporate Development	$413,000	—	$425,000	$425,000	$118,664	$44,612	$1,426,276

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	Chief Executive Officer and President	$524,435	—	$1,474,989	$1,474,948	$394,375	$45,395	$3,914,142
Ming Yan	Chief Technology Officer	$398,398	—	$432,497	$432,483	$187,247	$30,616	$1,481,241
Valerie Barnett	Chief Legal Officer and Corporate Secretary	$370,829	—	$439,999	$439,986	$139,432	$25,722	$1,415,968

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	Chief Executive Officer and President	$375,131	—	—	$4,250,000	$163,687	$29,684	$4,818,502
Ming Yan	Chief Technology Officer	$352,146	—	—	$2,125,000	$134,451	$28,180	$2,639,777
Patrik Jeanmonod	Chief Financial Officer	$292,865	—	—	$106,492	$2,125,000	$13,179	$2,550,715

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Wenbin Jiang	President and Chief Executive Officer	$241,487	$100,770	—	$69,097	—	$10,867	$422,221
Patrik Jeanmonod	Chief Financial Officer	$241,193	$88,066	—	$25,048	—	$10,854	$365,161
Ming Yan	Chief Technology Officer	$241,487	$88,174	—	$17,274	—	$10,867	$357,802

Executive changes

Person	Role	Change	Effective	Filed
Valerie Barnett	Chief Legal Officer and Corporate Secretary	Terminated	2026-06-29	2026-07-15
Philippe Busque, Ph.D.	Senior Vice President, Global Sales and Services	Resigned	2026-06-05	2026-06-02
Paul Christopher Williams	Chief Operating Officer	Resigned	2024-09-27	2024-09-12
William McCombe	Chief Financial Officer	Appointed	2024-03-18	2024-03-19
Chris Williams	Chief Operating Officer	Appointed	2022-10-31	2022-11-01

Key facts CIK 1831915 CUSIP 23285D109 13F (30d) 149 filings 146 filers Visit website Investor relations